Analyse

Magmil tablets from Samnam Pharmaceutical recorded the highest number of out‑of‑stock restock requests in August, with 26,673 alerts, according to BRPConnect data.

South Korea’s leading fashion‑beauty platform Musinsa partners with pharmacy chain Onnuri to open a combined ‘Pharmacy Beauty’ store in Hongdae, sparking interest in a new retail model.

Novartis Korea and Yuhan Yanghaeng have signed a strategic partnership to handle distribution and promotion of LabsiDo (remibrutinib) for chronic spontaneous urticaria in South Korea.

Daewoong Pharmaceutical’s botulinum toxin Nabota topped 1 trillion KRW in cumulative sales and held a Global Academic Program in Jeju for 40 key staff from partners in 22 countries.

Despite short‑term stock pressure from interest rates and supply issues, Korean pharma and biotech companies are pursuing M&A, tech exports and capacity investments, boosting fundamentals, says a Mirae Asset report.

Asia’s biotech ecosystem, bolstered by government investment and regulatory reforms, now accounts for about 43% of the global innovative therapy pipeline, shifting R&D focus from the US and Europe.

The Korea Disease Control and Prevention Agency says the 12.33 million influenza vaccine doses for the 2026‑2027 national immunization program will be delivered on schedule, despite early supply delays from Sanofi.

At the Pharmacy Growth Forum, H&J CEO Jeong Hye‑jin highlighted the need to identify skin concerns and offer minimal‑routine product selections to boost pharmacy cosmetics consulting.

Sky Labs has debuted on KOSDAQ, aiming to grow its ring‑type cuffless blood‑pressure monitor domestically and abroad while targeting a broader multi‑bio‑signal medical data platform.

Optima adds Dr. Rieon’s PDRN Rejuvenate serum and cream to its nationwide stores, expanding its K‑pharmacy beauty offerings.

Senatriple® vaginal soft capsule has achieved #1 sales in South Korea’s vaginitis treatment market, based on IQVIA 2025 forecast data, prompting Albozen Korea to launch an official brand site.

Daewoong Pharmaceutical will host the NABOTA®EDGE Global Academic Program in Jeju, training 40 key staff from partner companies in 22 countries to boost academic and marketing capabilities for its botulinum toxin, NABOTA.